Growth hormone axis
Tesamorelin
GHRH analogue (44 residues, N-terminally modified)
C221H366N72O67S5135.78 g/mol
Growth hormone axis
AOD-9604
Also listed as AOD9604
Growth hormone C-terminal fragment analogue (16 residues)
- Adipocyte signalling
- Formula
- C78H123N23O23S2
- Molar mass
- 1815.08 g/mol
- CAS number
- 221231-10-3
Identity
What the molecule is, from its PubChem record. These are the figures a certificate of analysis should agree with.
- Class
- Growth hormone C-terminal fragment analogue (16 residues)
- Sequence
H-YLRIVQCRSVEGSCGF-OH
- 16 residues: human growth hormone residues 177–191 with an added N-terminal tyrosine.
- The two cysteines (positions 7 and 14) are joined by a disulfide bond.
- Molecular formula
- C78H123N23O23S2
- Molar mass
- 1815.08 g/mol
- CAS number
- 221231-10-3
- PubChem
- CID 71300630
Checked against PubChem on 27 September 2026. Molar mass is calculated from the formula with standard atomic weights and agrees with PubChem’s published molecular weight. In sequences, H- marks a free N-terminus, -OH a free C-terminal acid and -NH₂ a C-terminal amide.
Research context
AOD-9604 is a 16-residue peptide made of residues 177–191 of human growth hormone plus an added N-terminal tyrosine, with a disulfide bond between its two cysteines. It is studied in adipocyte culture for lipid-metabolism signalling, and in receptor-binding work that compares it with full-length growth hormone.
Research use only. Everything on Vialwise concerns research-grade material sold for laboratory and analytical use only. It is not a registered medicine, is not supplied for human or veterinary use, and nothing here is medical advice.
Storage and handling
Store sealed lyophilised powder at −20 °C, dry and away from light.
Let the vial reach room temperature before opening, so moisture doesn’t condense on the powder.
Reconstitute in sterile water, or in the buffer your protocol specifies. Swirl gently rather than shake.
Its two cysteines form a disulfide bond. Keep reducing agents such as DTT out of the solvent.
Split the solution into single-use aliquots and keep them frozen, so no portion goes through repeated freeze–thaw.
General laboratory practice for this class of material; your institution’s own procedures come first. To work out concentration and aliquot volumes from a vial’s mass, use the reconstitution calculator. For the reasoning behind each step, read storing lyophilised peptides.
Published lab reports
Lab reports for AOD-9604 at Au Peptide Labs Our store
The one supplier whose full report list we have.
Open each lab-linked report on the lab’s own website to confirm it.
- Lab link
AOD-9604
Task #157235Added 11 Aug 2026
Verify at janoshik.com99.860%purity
Other suppliers publish their reports on their own sites. Where each supplier publishes its COAs
Vialwise is published by APL Research Pty Ltd, which also runs Au Peptide Labs. Every supplier, ours included, is scored on the same published checklist. How we handle this
Any supplier
Check any supplier’s AOD-9604 COA
These checks take a few minutes and work the same on a report from any supplier, ours included. The walkthrough shows each one on a real Janoshik report.
How to verify a Janoshik COAOpen it at the lab
The report should load on the testing lab’s own website from the verify link or task number, not only as a PDF or screenshot from the supplier.
Match the name
The sample should be named AOD-9604 or AOD9604, or a clear equivalent. A different compound name means a different report.
Match the mass
If the report includes a mass-spectrometry result: a deconvoluted average-mass result should sit close to 1815.08 g/mol; high-resolution reports give the slightly lower monoisotopic mass, and raw spectra show m/z for charged ions (mass ÷ charge). How HPLC and mass spec work.
Match the vial
The sample amount on the report should match the vial size you’re buying. A report on a different size or an older batch tells you less about the vial in front of you.
Related
Related compounds
Growth hormone axis
CJC-1295 (no DAC) + Ipamorelin
Two-peptide research blend (GHRH analogue and GHS-R1a agonist)
Blend of 2 peptides